Elaine Sanders-Bush - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
Serotonin receptors

167 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ye R, Carneiro AM, Han Q, Airey D, Sanders-Bush E, Zhang B, Lu L, Williams R, Blakely RD. Quantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression. Genes, Brain, and Behavior. 13: 261-75. PMID 24405699 DOI: 10.1111/gbb.12119  1
2014 Ye R, Carneiro AM, Airey D, Sanders-Bush E, Williams RW, Lu L, Wang J, Zhang B, Blakely RD. Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes, Brain, and Behavior. 13: 247-60. PMID 24102824 DOI: 10.1111/gbb.12092  1
2012 Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences of the United States of America. 109: 5469-74. PMID 22431635 DOI: 10.1073/pnas.1112345109  1
2012 Sanders-Bush E, Nichols CD. Serotonin Receptors and Neurotransmission Primer On the Autonomic Nervous System. 83-86. DOI: 10.1016/B978-0-12-386525-0.00017-2  1
2010 Olaghere da Silva UB, Morabito MV, Canal CE, Airey DC, Emeson RB, Sanders-Bush E. Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Frontiers in Neuroscience. 4: 26. PMID 20582266 DOI: 10.3389/neuro.23.001.2010  1
2010 Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M. National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Annals of Internal Medicine. 153: 176-81. PMID 20547888 DOI: 10.7326/0003-4819-153-3-201008030-00260  1
2010 Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. Nih Consensus and State-of-the-Science Statements. 27: 1-30. PMID 20445638  1
2010 Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology. 209: 163-74. PMID 20165943 DOI: 10.1007/s00213-010-1784-0  1
2009 Lanfranco MF, Seitz PK, Morabito MV, Emeson RB, Sanders-Bush E, Cunningham KA. An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. Journal of Neuroscience Methods. 179: 247-57. PMID 19428534 DOI: 10.1016/j.jneumeth.2009.01.027  1
2009 Canal CE, Mahautmr KC, Cao C, Sanders-Bush E, Airey DC. RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation. Journal of Neurochemistry. 108: 1136-42. PMID 19154337 DOI: 10.1111/j.1471-4159.2008.05852.x  1
2009 Shelton RC, Sanders-Bush E, Manier DH, Lewis DA. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience. 158: 1406-15. PMID 19111907 DOI: 10.1016/j.neuroscience.2008.11.036  1
2008 Sanders-Bush E, Airey DC. Centennial perspective: serotonin receptors. Molecular Interventions. 8: 200-3. PMID 19015382 DOI: 10.1124/mi.8.5.1  1
2008 Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes, Brain, and Behavior. 7: 487-95. PMID 18081710 DOI: 10.1111/j.1601-183X.2007.00384.x  1
2008 Benneyworth MA, Smith RL, Sanders-Bush E. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2206-16. PMID 17957214 DOI: 10.1038/sj.npp.1301600  1
2007 Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Molecular Pharmacology. 72: 477-84. PMID 17526600 DOI: 10.1124/mol.107.035170  1
2007 Garcia EE, Smith RL, Sanders-Bush E. Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology. 52: 1671-7. PMID 17493641 DOI: 10.1016/j.neuropharm.2007.03.013  1
2007 Hackler EA, Turner GH, Gresch PJ, Sengupta S, Deutch AY, Avison MJ, Gore JC, Sanders-Bush E. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. The Journal of Pharmacology and Experimental Therapeutics. 320: 1023-9. PMID 17138863 DOI: 10.1124/jpet.106.113357  1
2007 Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. The Journal of Pharmacology and Experimental Therapeutics. 320: 662-9. PMID 17077317 DOI: 10.1124/jpet.106.112946  1
2007 Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E. Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biological Psychiatry. 61: 167-73. PMID 16697352 DOI: 10.1016/j.biopsych.2005.12.018  1
2006 Tomlinson ID, Gies AP, Gresch PJ, Dillard J, Orndorff RL, Sanders-Bush E, Hercules DM, Rosenthal SJ. Universal polyethylene glycol linkers for attaching receptor ligands to quantum dots. Bioorganic & Medicinal Chemistry Letters. 16: 6262-6. PMID 17000112 DOI: 10.1016/j.bmcl.2006.09.031  1
2006 Hackler EA, Airey DC, Shannon CC, Sodhi MS, Sanders-Bush E. 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice. Neuroscience Research. 55: 96-104. PMID 16580757 DOI: 10.1016/j.neures.2006.02.005  1
2005 Bentzen EL, Tomlinson ID, Mason J, Gresch P, Warnement MR, Wright D, Sanders-Bush E, Blakely R, Rosenthal SJ. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjugate Chemistry. 16: 1488-94. PMID 16287246 DOI: 10.1021/bc0502006  1
2005 Sodhi MS, Airey DC, Lambert W, Burnet PW, Harrison PJ, Sanders-Bush E. A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Molecular Pharmacology. 68: 711-9. PMID 15917433 DOI: 10.1124/mol.105.014134  1
2005 Fentress HM, Grinde E, Mazurkiewicz JE, Backstrom JR, Herrick-Davis K, Sanders-Bush E. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. The Pharmacogenomics Journal. 5: 244-54. PMID 15912142 DOI: 10.1038/sj.tpj.6500315  1
2005 Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1693-702. PMID 15756304 DOI: 10.1038/sj.npp.1300711  1
2005 Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology. 179: 854-62. PMID 15645221 DOI: 10.1007/s00213-004-2108-z  1
2005 Akin D, Manier DH, Sanders-Bush E, Shelton RC. Signal transduction abnormalities in melancholic depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 5-16. PMID 15500705 DOI: 10.1017/S146114570400478X  1
2004 Hazelwood LA, Sanders-Bush E. His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation. Molecular Pharmacology. 66: 1293-300. PMID 15496511 DOI: 10.1124/mol.66.5.  1
2004 Nichols CD, Sanders-Bush E. Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins. Journal of Neurochemistry. 90: 576-84. PMID 15255935 DOI: 10.1111/j.1471-4159.2004.02515.x  1
2004 Akin D, Manier DH, Sanders-Bush E, Shelton RC. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2081-7. PMID 15187984 DOI: 10.1038/sj.npp.1300505  1
2004 Sodhi MS, Sanders-Bush E. Serotonin and brain development. International Review of Neurobiology. 59: 111-74. PMID 15006487 DOI: 10.1016/S0074-7742(04)59006-2  1
2004 McGrew L, Price RD, Hackler E, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Molecular Pharmacology. 65: 252-6. PMID 14722258 DOI: 10.1124/mol.65.1.252  1
2003 Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-ht2 receptors: molecular and genomic diversity. Molecular Interventions. 3: 319-30. PMID 14993464 DOI: 10.1124/mi.3.6.319  1
2003 Parker LL, Backstrom JR, Sanders-Bush E, Shieh BH. Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates its interaction with multiple PDZ protein 1. The Journal of Biological Chemistry. 278: 21576-83. PMID 12682077 DOI: 10.1074/jbc.M210973200  1
2003 Nichols CD, Garcia EE, Sanders-Bush E. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Research. Molecular Brain Research. 111: 182-8. PMID 12654518 DOI: 10.1016/S0169-328X(03)00029-9  1
2003 Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience. 116: 107-17. PMID 12535944 DOI: 10.1016/S0306-4522(02)00580-8  1
2003 Smith RL, Barrett RJ, Sanders-Bush E. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. Psychopharmacology. 166: 61-8. PMID 12474110 DOI: 10.1007/s00213-002-1252-6  1
2002 McGrew L, Chang MS, Sanders-Bush E. Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits. Molecular Pharmacology. 62: 1339-43. PMID 12435801 DOI: 10.1124/mol.62.6.1339  1
2002 Nichols CD, Ronesi J, Pratt W, Sanders-Bush E. Hallucinogens and Drosophila: linking serotonin receptor activation to behavior. Neuroscience. 115: 979-84. PMID 12435434 DOI: 10.1016/S0306-4522(02)00354-8  1
2002 Gresch PJ, Strickland LV, Sanders-Bush E. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience. 114: 707-13. PMID 12220572 DOI: 10.1016/S0306-4522(02)00349-4  1
2002 Nichols CD, Sanders-Bush E. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 634-42. PMID 11927188 DOI: 10.1016/S0893-133X(01)00405-5  1
2002 Smith RL, Gresch PJ, Barrett RJ, Sanders-Bush E. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. Pharmacology, Biochemistry, and Behavior. 72: 77-85. PMID 11900772 DOI: 10.1016/S0091-3057(01)00723-7  1
2001 Peavy RD, Chang MS, Sanders-Bush E, Conn PJ. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9619-28. PMID 11739572  1
2001 Price RD, Weiner DM, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. The Journal of Biological Chemistry. 276: 44663-8. PMID 11572865 DOI: 10.1074/jbc.M106745200  1
2001 Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. British Journal of Pharmacology. 134: 386-92. PMID 11564657 DOI: 10.1038/sj.bjp.0704255  1
2001 Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 478-91. PMID 11282248 DOI: 10.1016/S0893-133X(00)00223-2  1
2001 Bubser M, Backstrom JR, Sanders-Bush E, Roth BL, Deutch AY. Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum. Synapse (New York, N.Y.). 39: 297-304. PMID 11169779 DOI: 10.1002/1098-2396(20010315)39:4<297::AID-SYN1012>3.0.CO;2-Q  1
2000 Chang MS, Tam JP, Sanders-Bush E. Dissecting intracellular signaling pathways with membrane-permeable peptides. Science's Stke : Signal Transduction Knowledge Environment. 2000: pl1. PMID 11752605 DOI: 10.1126/stke.2000.47.pl1  1
2000 Price RD, Sanders-Bush E. RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Molecular Pharmacology. 58: 859-62. PMID 10999958  1
2000 Backstrom JR, Price RD, Reasoner DT, Sanders-Bush E. Deletion of the serotonin 5-HT2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses. The Journal of Biological Chemistry. 275: 23620-6. PMID 10816555 DOI: 10.1074/jbc.M000922200  1
2000 Chang M, Zhang L, Tam JP, Sanders-Bush E. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. The Journal of Biological Chemistry. 275: 7021-9. PMID 10702266 DOI: 10.1074/jbc.275.10.7021  1
1999 Smith RL, Barrett RJ, Sanders-Bush E. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology. 144: 248-54. PMID 10435391 DOI: 10.1007/s002130051000  1
1999 Backstrom JR, Chang MS, Chu H, Niswender CM, Sanders-Bush E. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 77S-81S. PMID 10432492 DOI: 10.1016/S0893-133X(99)00005-6  1
1999 Bancila M, Vergé D, Rampin O, Backstrom JR, Sanders-Bush E, McKenna KE, Marson L, Calas A, Giuliano F. 5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat. Neuroscience. 92: 1523-37. PMID 10426504 DOI: 10.1016/S0306-4522(99)00082-2  1
1999 Willins DL, Berry SA, Alsayegh L, Backstrom JR, Sanders-Bush E, Friedman L, Roth BL. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 91: 599-606. PMID 10366017 DOI: 10.1016/S0306-4522(98)00653-8  1
1999 Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. The Journal of Biological Chemistry. 274: 9472-8. PMID 10092629 DOI: 10.1074/jbc.274.14.9472  1
1999 Grotewiel MS, Sanders-Bush E. Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expression. Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 21-7. PMID 9933146  1
1998 Willins DL, Alsayegh L, Berry SA, Backstrom JR, Sanders-Bush E, Friedman L, Khan N, Roth BL. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo. Annals of the New York Academy of Sciences. 861: 121-7. PMID 9928248 DOI: 10.1111/j.1749-6632.1998.tb10182.x  1
1998 Niswender CM, Sanders-Bush E, Emeson RB. Identification and characterization of RNA editing events within the 5-HT2C receptor. Annals of the New York Academy of Sciences. 861: 38-48. PMID 9928237 DOI: 10.1111/j.1749-6632.1998.tb10171.x  1
1998 Smith RL, Canton H, Barrett RJ, Sanders-Bush E. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacology, Biochemistry, and Behavior. 61: 323-30. PMID 9768567 DOI: 10.1016/S0091-3057(98)00110-5  1
1998 Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. The Journal of Biological Chemistry. 273: 5109-16. PMID 9556548  1
1998 Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. The Journal of Biological Chemistry. 273: 5109-16. PMID 9478963 DOI: 10.1074/jbc.273.9.5109  1
1997 Backstrom JR, Sanders-Bush E. Generation of anti-peptide antibodies against serotonin 5-HT2A and 5-HT2C receptors. Journal of Neuroscience Methods. 77: 109-17. PMID 9402563 DOI: 10.1016/S0165-0270(97)00102-7  1
1997 Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. Journal of Medicinal Chemistry. 40: 2997-3008. PMID 9301661 DOI: 10.1021/jm970219x  1
1997 Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 387: 303-8. PMID 9153397 DOI: 10.1038/387303a0  1
1997 Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H, Kobilka BK. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. The Journal of Biological Chemistry. 272: 2587-90. PMID 9006889 DOI: 10.1074/jbc.272.5.2587  1
1996 Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Molecular Pharmacology. 50: 799-807. PMID 8863824  1
1996 Westphal RS, Sanders-Bush E. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division. Molecular Pharmacology. 49: 474-80. PMID 8643087  1
1995 Onaivi ES, Bishop-Robinson C, Darmani NA, Sanders-Bush E. Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Life Sciences. 57: 2455-66. PMID 8847967 DOI: 10.1016/0024-3205(95)02242-9  1
1995 Backstrom JR, Westphal RS, Canton H, Sanders-Bush E. Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides. Brain Research. Molecular Brain Research. 33: 311-8. PMID 8750891 DOI: 10.1016/0169-328X(95)00156-M  1
1995 Monte AP, Marona-Lewicka D, Kanthasamy A, Sanders-Bush E, Nichols DE. Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes. Journal of Medicinal Chemistry. 38: 958-66. PMID 7699712  1
1995 Westphal RS, Backstrom JR, Sanders-Bush E. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Molecular Pharmacology. 48: 200-5. PMID 7651352  1
1995 Ike J, Canton H, Sanders-Bush E. Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysis. Brain Research. 678: 49-54. PMID 7620898 DOI: 10.1016/0006-8993(95)00143-E  1
1995 Smith RL, Barrett RJ, Sanders-Bush E. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. The Journal of Pharmacology and Experimental Therapeutics. 275: 1050-7. PMID 7473132  1
1995 Geyer MA, Lorens SA, Sanders-Bush E. Editorial commentary Behavioural Brain Research. 73: v.  1
1994 Sanders-Bush E. Neurochemical evidence that hallucinogenic drugs are 5-HT1c receptor agonists: what next? Nida Research Monograph. 146: 203-13. PMID 8742800  1
1994 Mayer SE, Sanders-Bush E. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport. Molecular Pharmacology. 45: 991-6. PMID 8190114  1
1994 Westphal RS, Sanders-Bush E. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Molecular Pharmacology. 46: 937-42. PMID 7969083  1
1994 Grotewiel MS, Chu H, Sanders-Bush E. m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts. The Journal of Pharmacology and Experimental Therapeutics. 271: 1122-6. PMID 7965773  1
1994 Grotewiel MS, Sanders-Bush E. Regulation of serotonin2A receptors in heterologous expression systems. Journal of Neurochemistry. 63: 1255-60. PMID 7931277  1
1994 Barker EL, Westphal RS, Schmidt D, Sanders-Bush E. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. The Journal of Biological Chemistry. 269: 11687-90. PMID 7909313  1
1993 Mayer SE, Sanders-Bush E. Sodium-dependent antiporters in choroid plexus epithelial cultures from rabbit. Journal of Neurochemistry. 60: 1308-16. PMID 8384246  1
1993 Barker EL, Sanders-Bush E. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Molecular Pharmacology. 44: 725-30. PMID 8232222  1
1992 Glennon RA, Teitler M, Sanders-Bush E. Hallucinogens and serotonergic mechanisms. Nida Research Monograph. 119: 131-5. PMID 1435968  1
1992 Burris KD, Sanders-Bush E. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Molecular Pharmacology. 42: 826-30. PMID 1359397  1
1992 Esterle TM, Sanders-Bush E. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 4775-82. PMID 1334504  1
1991 Esterle TM, Sanders-Bush E. From neurotransmitter to gene: identifying the missing links. Trends in Pharmacological Sciences. 12: 375-9. PMID 1684881 DOI: 10.1016/0165-6147(91)90607-T  1
1991 Burris KD, Breeding M, Sanders-Bush E. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 258: 891-6. PMID 1679849  1
1991 Sanders-Bush E, Breeding M. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs. Psychopharmacology. 105: 340-6. PMID 1665919 DOI: 10.1007/BF02244428  1
1991 Barker EL, Burris KD, Sanders-Bush E. Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus. Brain Research. 552: 330-2. PMID 1655172 DOI: 10.1016/0006-8993(91)90099-H  1
1990 Sanders-Bush E, Breeding M. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity. The Journal of Pharmacology and Experimental Therapeutics. 252: 984-8. PMID 2319481  1
1990 Sanders-Bush E, Tsutsumi M, Burris KD. Serotonin receptors and phosphatidylinositol turnover. Annals of the New York Academy of Sciences. 600: 224-35; discussion 2. PMID 2252311  1
1990 Smith RL, Barrett RJ, Sanders-Bush E. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior. The Journal of Pharmacology and Experimental Therapeutics. 254: 484-8. PMID 2166792  1
1990 Tsutsumi M, Sanders-Bush E. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor. The Journal of Pharmacology and Experimental Therapeutics. 254: 253-7. PMID 2164094  1
1990 Sanders-Bush E. Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 3: 411-6. PMID 1964049  1
1990 Sanders-Bush E, Tsutsumi M. Role of serotonin 5HT1c receptors in the regulation of protein synthesis by choroid plexus epithelial cells in culture European Journal of Pharmacology. 183: 2352. DOI: 10.1016/0014-2999(90)93914-C  1
1990 Mayer S, Sanders-Bush E. Na+/H+ antiport in cultured choroid plexus epithelium European Journal of Pharmacology. 183: 1172.  1
1989 Sanders-Bush E, Breeding M, Knoth K, Tsutsumi M. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology. 99: 64-9. PMID 2550988 DOI: 10.1007/BF00634454  1
1989 Tsutsumi M, Skinner MK, Sanders-Bush E. Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells. Regulation by serotonin and cyclic adenosine 3',5'-monophosphate. The Journal of Biological Chemistry. 264: 9626-31. PMID 2542315  1
1988 Sanders-Bush E, Breeding M. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus. The Journal of Pharmacology and Experimental Therapeutics. 247: 169-73. PMID 3139864  1
1988 Sanders-Bush E, Burris KD, Knoth K. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. The Journal of Pharmacology and Experimental Therapeutics. 246: 924-8. PMID 2843634  1
1988 Gillespie DD, Manier DH, Sanders-Bush E, Sulser F. The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation. The Journal of Pharmacology and Experimental Therapeutics. 244: 154-9. PMID 2826764  1
1987 Sanders-Bush E, Breeding M, Roznoski M. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. European Journal of Pharmacology. 133: 199-204. PMID 3816985 DOI: 10.1016/0014-2999(87)90151-8  1
1987 Conn PJ, Janowsky A, Sanders-Bush E. Denervation supersensitivity of 5-HT-1c receptors in rat choroid plexus. Brain Research. 400: 396-8. PMID 3815085 DOI: 10.1016/0006-8993(87)90641-X  1
1987 Conn PJ, Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. The Journal of Pharmacology and Experimental Therapeutics. 242: 552-7. PMID 3039120  1
1987 Manier DH, Gillespie DD, Sanders-Bush E, Sulser F. The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine. Naunyn-Schmiedeberg's Archives of Pharmacology. 335: 109-14. PMID 3031514 DOI: 10.1007/BF00177710  1
1987 Sulser F, Sanders-Bush E. The serotonin-norepinephrine link hypothesis of affective disorders: receptor-receptor interactions in brain. Advances in Experimental Medicine and Biology. 221: 489-502. PMID 2829588  1
1987 Conn PJ, Sanders-Bush E. Central serotonin receptors: effector systems, physiological roles and regulation. Psychopharmacology. 92: 267-77. PMID 2819915 DOI: 10.1007/BF00210830  1
1986 Blackshear MA, Martin LL, Sanders-Bush E. Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists. Neuropharmacology. 25: 1267-71. PMID 3796800 DOI: 10.1016/0028-3908(86)90146-2  1
1986 Sanders-Bush E, Conn PJ. Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis. Psychopharmacology Bulletin. 22: 829-36. PMID 3025911  1
1986 Conn PJ, Sanders-Bush E. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 3669-75. PMID 3025382  1
1986 Conn PJ, Sanders-Bush E. Agonist-induced phosphoinositide hydrolysis in choroid plexus. Journal of Neurochemistry. 47: 1754-60. PMID 3021903  1
1986 Conn PJ, Sanders-Bush E. Biochemical characterization of serotonin stimulated phosphoinositide turnover. Life Sciences. 38: 663-9. PMID 3003490 DOI: 10.1016/0024-3205(86)90060-3  1
1986 Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proceedings of the National Academy of Sciences of the United States of America. 83: 4086-8. PMID 2940597  1
1985 Sanders-Bush E, Conn J, Sulser F. The serotonin/norepinephrine-linked beta-adrenoceptor system and the mode of action of antidepressants. Psychopharmacology Bulletin. 21: 373-8. PMID 2994152  1
1985 Conn PJ, Sanders-Bush E. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. The Journal of Pharmacology and Experimental Therapeutics. 234: 195-203. PMID 2989504  1
1985 Conn PJ, Sanders-Bush E. Regional analysis of serotonin (5HT) stimulated phosphatidylinositol (PI) turnover in rat brain Federation Proceedings. 44: No. 8280.  1
1984 Friedman RL, Barrett RJ, Sanders-Bush E. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. The Journal of Pharmacology and Experimental Therapeutics. 228: 628-35. PMID 6707913  1
1984 Friedman RL, Sanders-Bush E, Barrett RL. Clozapine blocks disruptive and discriminative stimulus effects of quipazine. European Journal of Pharmacology. 106: 191-3. PMID 6529966 DOI: 10.1016/0014-2999(84)90695-2  1
1984 Conn PJ, Sanders-Bush E. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology. 23: 993-6. PMID 6483122 DOI: 10.1016/0028-3908(84)90017-0  1
1983 Blackshear MA, Friedman RL, Sanders-Bush E. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 324: 125-9. PMID 6646240 DOI: 10.1007/BF00497017  1
1983 Friedman R, Barrett RJ, Sanders-Bush E. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor. Psychopharmacology. 80: 209-13. PMID 6137018 DOI: 10.1007/BF00436154  1
1982 Martin LL, Sanders-Bush E. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 165-70. PMID 7155196 DOI: 10.1007/BF00505480  1
1982 Blackshear MA, Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. The Journal of Pharmacology and Experimental Therapeutics. 221: 303-8. PMID 7077527  1
1982 Martin LL, Sanders-Bush E. The serotonin autoreceptor: antagonism by quipazine. Neuropharmacology. 21: 445-50. PMID 6981071 DOI: 10.1016/0028-3908(82)90029-6  1
1982 Barrett RJ, Blackshear MA, Sanders-Bush E. Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors. Psychopharmacology. 76: 29-35. PMID 6805004 DOI: 10.1007/BF00430750  1
1982 Sanders-Bush E. Regulation of serotonin storage and release. Advances in Biochemical Psychopharmacology. 34: 17-34. PMID 6127916  1
1982 Blackshear MA, Sanders-Bush E. Effects of mianserin on serotonin receptor subtypes Federation Proceedings. 41: 7984.  1
1982 Martin LL, Sanders-Bush E. Characterization of the serotonin (5HT) autoreceptor Federation Proceedings. 41: No. 6187.  1
1982 Friedman R, Sanders-Bush E, Barrett RJ. Serotonin antagonists in models of serotonin receptor subtypes Federation Proceedings. 41: No. 6244.  1
1981 Blackshear MA, Steranka LR, Sanders-Bush E. Multiple serotonin receptors: regional distribution and effect of Raphe lesions. European Journal of Pharmacology. 76: 325-34. PMID 7327207 DOI: 10.1016/0014-2999(81)90103-5  1
1980 Steranka LR, Sanders-Bush E. Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. European Journal of Pharmacology. 65: 439-43. PMID 7408949  1
1980 Bush MT, Sanders-Bush E. Diazomethane: improved analytical and distillation techniques for small quantities and some synthetic applications. Analytical Biochemistry. 106: 351-62. PMID 6108732  1
1979 Steranka LR, Sanders-Bush E. Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochemical Pharmacology. 28: 3103-7. PMID 518708 DOI: 10.1016/0006-2952(79)90619-1  1
1979 Mobley PL, Sanders-Bush E, Smith HE, Sulser F. Modification of the noradrenergic cyclic AMP generating system in the rat limbic forebrain by amphetamine: role of its hydroxylated metabolites. Naunyn-Schmiedeberg's Archives of Pharmacology. 306: 267-73. PMID 224324 DOI: 10.1007/BF00507113  1
1979 Steranka LR, Sanders-Bush E. Long-term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology. 18: 895-903. PMID 95210 DOI: 10.1016/0028-3908(79)90088-1  1
1979 Sanders-Bush E. Psychoactive drugs: Biochemical mechanisms of action Psychopharmacology Bulletin. 15: 85-86.  1
1978 Steranka LR, Sanders-Bush E. Long-term effects of continuous exposure to p-chloroamphetamine on central serotonergic mechanisms in mice. Biochemical Pharmacology. 27: 2033-7. PMID 718726 DOI: 10.1016/0006-2952(78)90063-1  1
1978 Steranka LR, Sanders-Bush E. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism. The Journal of Pharmacology and Experimental Therapeutics. 206: 460-7. PMID 682126  1
1978 Massari VJ, Tizabi Y, Sanders-Bush E. Evaluation of the neurotoxic effects of p-chloroamphetamine: a histological and biochemical study. Neuropharmacology. 17: 541-8. PMID 80767 DOI: 10.1016/0028-3908(78)90062-X  1
1978 Steranka LR, Sanders-Bush E. Biochemical studies of the mechanism of the depletion of brain serotonin (5HT) by fenfluramine Pharmacologist. 20: No. 164.  1
1977 Steranka L, Sanders-Bush E. Temporal effects of p-chloroamphetamine on catecholamine synthesis. European Journal of Pharmacology. 45: 83-6. PMID 891623 DOI: 10.1016/0014-2999(77)90062-0  1
1977 Steranka L, Bessent R, Sanders-Bush E. Reversible and irreversible effects of p-chloroamphetamine on brain serotonin in mice. Communications in Psychopharmacology. 1: 447-54. PMID 606480  1
1977 El-Yousef MK, Steranka L, Sanders-Bush E. Rapid tolerance to the motor effects of p-chloroamphetamine in rats. Psychopharmacology. 55: 109-14. PMID 414268 DOI: 10.1007/BF01457844  1
1977 Sanders-Bush E, Massari VJ. Actions of drugs that deplete serotonin. Federation Proceedings. 36: 2149-53. PMID 141378  1
1977 Steranka LR, Sanders-Bush E, Barrett RJ. Tolerance to p-chloroamphetamines effects on Sidman avoidance performance and catecholamine metabolism. Neuropharmacology. 16: 761-9. PMID 22829 DOI: 10.1016/0028-3908(77)90134-4  1
1977 Steranka LR, Barrett RJ, Sanders-Bush E. Facilitation of Sidman avoidance performance by p-chloroamphetamine: role of biogenic amines. Neuropharmacology. 16: 751-9. PMID 22828 DOI: 10.1016/0028-3908(77)90133-2  1
1976 Sanders-Bush E, Oates JA, Bush MT. Metabolism of bufotenine-2'-14C in human volunteers. Life Sciences. 19: 1407-11. PMID 994734 DOI: 10.1016/0024-3205(76)90441-0  1
1975 Sekerke HJ, Smith HE, Bushing JA, Sanders-Bush E. Correlation between brain levels and biochemical effects of the optical isomers of p-chloroamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 193: 835-44. PMID 1151732  1
1975 Sanders-Bush E, Bushing JA, Sulser F. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 192: 33-41. PMID 1123726  1
1975 Massari VJ, Sanders-Bush E. Synaptosomal uptake and levels of serotonin in rat brain areas after p-chloroamphetamine or B-9 lesions. European Journal of Pharmacology. 33: 419-22. PMID 1102320 DOI: 10.1016/0014-2999(75)90190-9  1
1975 Gallager DW, Sanders-Bush E, Aghajanian GK, Sulser F. An evaluation of the use of intraventricularly administered [3H]5-hydroxytryptamine as a marker for endogenous brain 5-hydroxytryptamine. Brain Research. 93: 111-22. PMID 1040550 DOI: 10.1016/0006-8993(75)90289-9  1
1974 Smith HE, Burrows EP, Miano JD, Mount CD, Sanders-Bush E, Sulser F. Action of (S)-and(R)-para-substituted amphetamine hydrochlorides and (alphaS)-and (alphaR)-p-chloronorephedrine and (alphaS)-and (alphaR)-p-chloronorpseudoephedrine hydrochlorides on the level of 5-hydroxytryptamine and the activity of tryptophan hydroxylase in rat brain. Journal of Medicinal Chemistry. 17: 416-21. PMID 4830539  1
1974 Schaefer GJ, Barrett RJ, Sanders-Bush E, Vorhees CV. p-Chloroamphetamine: evidence against a serotonin mediated learning deficit in PKU. Pharmacology, Biochemistry, and Behavior. 2: 783-9. PMID 4478023 DOI: 10.1016/0091-3057(74)90111-7  1
1974 Sanders-Bush E, Gallager DA, Sulser F. On the mechanism of brain 5-hydroxytryptamine depletion by p-chloroamphetamine and related drugs and the specificity of their action. Advances in Biochemical Psychopharmacology. 10: 185-94. PMID 4276953  1
1974 Sulser F, Sanders-Bush E. Halogen substitution of amphetamine biochemical and pharmacological consequences Biochemical Pharmacology. 23: 826-832. DOI: 10.1016/0006-2952(74)90142-7  1
1974 Smith HE, Burrows EP, Miano JD, Mount CD, Sanders-Bush E, Sulser F. Action of (S)- and (R)-para-substituted amphetamine hydrochlorides and (αS)- and (αR)-p-chloronorephedrine and (αS)- and (αR)-p-chloronorpseudoephedrine hydrochlorides on the level of 5-hydroxytryptamine and the activity of tryptophan hydroxylase in rat brain Journal of Medicinal Chemistry. 17: 416-421.  1
1972 Yarbrough GG, Buxbaum DM, Sanders-Bush E. Increased serotonin turnover in acutely morphine-treated mice Biochemical Pharmacology. 21: 2667-2669. PMID 4661628 DOI: 10.1016/0006-2952(72)90240-7  1
1972 Gallager DW, Sanders-Bush E, Sulser F. Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol. Psychopharmacologia. 26: 337-45. PMID 4638199 DOI: 10.1007/BF00421899  1
1972 Sanders-Bush E, Bushing JA, Sulser F. Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. European Journal of Pharmacology. 20: 385-8. PMID 4264678 DOI: 10.1016/0014-2999(72)90204-X  1
1972 Sanders-Bush E, Bushing JA, Sulser F. p-Chloroamphetamine--inhibition of cerebral tryptophan hydroxylase. Biochemical Pharmacology. 21: 1501-10. PMID 4260485 DOI: 10.1016/0006-2952(72)90375-9  1
1971 Yarbrough GG, Buxbaum DM, Sanders-Bush E. Increased serotonin turnover in the acutely morphine treated rat. Life Sciences. Pt. 1: Physiology and Pharmacology. 10: 977-83. PMID 5570138 DOI: 10.1016/0024-3205(71)90255-4  1
1971 Schmidt MJ, Sanders-Bush E. Tryptophan hydroxylase activity in developing rat brain. Journal of Neurochemistry. 18: 2549-51. PMID 5316362  1
1971 Miller KW, Sanders-Bush E, Dingell JV. p-Chloramphetamine--species differences in the rate of disappearance and the lowering of cerebral serotonin. Biochemical Pharmacology. 20: 500-3. PMID 5150149 DOI: 10.1016/0006-2952(71)90092-X  1
1971 Sulser F, Sanders-Bush E. Effect of drugs on amines in the CNS. Annual Review of Pharmacology. 11: 209-30. PMID 4948498 DOI: 10.1146/annurev.pa.11.040171.001233  1
1970 Strada SJ, Sanders-Bush E, Sulser F. p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine. Biochemical Pharmacology. 19: 2621-9. PMID 5478286 DOI: 10.1016/0006-2952(70)90012-2  1
1970 Sanders-Bush E, Sulser F. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin. The Journal of Pharmacology and Experimental Therapeutics. 175: 419-26. PMID 5312363  1
Show low-probability matches.